Ryan T. Flynn

University of Iowa

Papers

1

Total Citations

10

H-Index

1

About

Ryan T. Flynn is a leading figure in the advancement of brachytherapy, with a primary focus on developing innovative, high-precision radiation treatments for prostate cancer. His most significant contribution is the conceptualization and development of a novel system for 169Yb-based rotating shield brachytherapy (RSBT), which enables a single-fraction, single-catheter robotic delivery regimen. This work, published in 2020, has already garnered 10 citations, reflecting its immediate impact on the field. By introducing a rotating shield within a single catheter that can be deployed through multiple implanted needles, Flynn’s approach dramatically enhances dose conformality while minimizing treatment time and invasiveness. His research addresses a critical need for more efficient and patient-friendly prostate cancer therapies, potentially reducing the logistical burden of multi-fraction treatments. Flynn’s innovative RSBT platform represents a paradigm shift in brachytherapy, offering a path toward safer, more effective, and more accessible radiotherapy. His work is foundational for researchers and clinicians seeking to push the boundaries of image-guided, adaptive brachytherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
<sup>169</sup>Yb‐based rotating shield brachytherapy for prostate cancer
10 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Iowa

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago